Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.

Adolescent hyperglycemia and worsening insulin resistance are associated with an increased risk for worsening structural and functional cardiac damage.

Glucagon-like peptide-1 receptor agonists are tied to a reduction in alcohol intake in patients being treated for obesity.

The FDA has approved Optison for use in pediatric patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricle endocardial borders.

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

Maternal deaths increased between 2000 and 2019, and another sharp increase was recorded in 2021 during the COVID-19 pandemic.

Data-driven clustering reveals distinct obesity phenotypes with unique clinical, behavioral, microbiome features, and differential GLP-1 responses.

Researchers have found that, among nulliparous patients, hypertensive disorders of pregnancy significantly increase risk for incident atrial fibrillation.